Quick Answer
Ocean Biomedical, Inc. reported Earnings Per Share Diluted of $0.34 (loss) per share for the year ending 2024.
- Ocean Biomedical, Inc. showed an increase of +92.2% in Earnings Per Share Diluted from 2023 to 2024.
- This data is from Ocean Biomedical, Inc.'s annual report (Form 10-K), filed with the SEC on April 8, 2025.
- XBRL data for this metric is available from 2022 to 2024 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2022: $0.31 (loss) per share | Q3 2022: $0.16 (loss) per share | Q1 2023: $2.90 (loss) per share | Q2 2023: $0.43 (loss) per share | Q3 2023: $0.53 (loss) per share | Q1 2024: $0.48 per share | Q2 2024: $0.63 (loss) per share | Q3 2024: $0.13 (loss) per share | Q1 2025: $0.09 (loss) per share.
- Over the full 3 years of available data (2022 to 2024), Ocean Biomedical, Inc.'s Earnings Per Share Diluted has grown by 54.1%.
- Historical annual values: Fiscal year 2024: $0.34 (loss) per share | Fiscal year 2023: $4.35 (loss) per share | Fiscal year 2022: $0.74 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: